Low Vitamin D Levels Up Risk for COVID-19 Hospitalization
By Lori Solomon HealthDay Reporter
THURSDAY, July 31, 2025 -- Vitamin D insufficiency and deficiency are tied to higher risk of being hospitalized for COVID-19, according to a study published online July 18 in PLOS ONE.
Maria J. Monroy-Iglesias, Ph.D., from King’s College London, and colleagues used data from the U.K. biobank (151,543 individuals with at least one serum vitamin D level measurement at baseline, 2006 to 2010) to assess associations between vitamin D levels and risk of COVID-19 infection and hospitalization.
The researchers found that vitamin D insufficiency (adjusted odds ratio [aOR], 0.97; 95 percent confidence interval [CI], 0.94 to 1.00) and deficiency (aOR, 0.95; 95 percent CI, 0.90 to 0.99) were associated with slightly lower odds of COVID-19 infection. There was variance by race and ethnicity, with Asian and Black participants having higher odds of COVID-19 infection with vitamin D deficiency, while vitamin D insufficiency in White participants was associated with slightly lower odds of COVID-19 infection. Both vitamin D insufficiency (aOR, 1.19; 95 percent CI, 1.08 to 1.32) and deficiency (aOR, 1.44; 95 percent CI, 1.25 to 1.66) were associated with higher odds of COVID-19 hospitalization.
"COVID-19 may not be the threat it once was, but it still affects peoples’ well-being," coauthor Kerri Beckmann, Ph.D., from the University of South Australia in Adelaide, said in a statement. "Understanding who is most at risk helps those individuals take extra precautions, including monitoring their vitamin D levels."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Further Support and Information on COVID-19
Read this next
COVID-19 Infection Linked to Accelerated Vascular Aging
MONDAY, Aug. 18, 2025 -- COVID-19 is associated with early vascular aging, as assessed by carotid-femoral pulse wave velocity (PWV), an established biomarker of large artery...
Larazotide May Speed Recovery in Children With Multisystem Inflammatory Syndrome
WEDNESDAY, Aug. 6, 2025 -- Treatment of multisystem inflammatory syndrome in children (MISC), a postacute sequela of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)...
COVID-19 mRNA Vaccine Targeting Omicron JN.1 Lineage Safe
WEDNESDAY, Aug. 6, 2025 -- Vaccination with the updated COVID-19 mRNA vaccine containing the severe acute respiratory syndrome coronavirus-2 Omicron JN.1 lineage was not...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.